INTERNATIONAL PATENT: GMAX BIOPHARM LLC, 鸿运华宁（杭州）生物医药有限公司 FILES APPLICATION FOR "PHARMACEUTICALLY STABLE SOLUTION FORMULATION WITH GIPR ANTIBODY FUSION PROTEIN AND USE THEREOF"

Posted On: 2026-02-02

GENEVA, Feb. 2 -- GMAX BIOPHARM LLC (Room 302, 3/F Building 2, 288 Qiuyi Road, Binjiang District, HangzhouHangzhou, Zhejiang 310056), 鸿运华宁（杭州）生物医药有限公司 (中国浙江省杭州市滨江区秋溢路288号东冠高新科技园二号楼3层302室) filed a patent application (PCT/CN2025/110595) for "PHARMACEUTICALLY STABLE SOLUTION FORMULATION WITH GIPR ANTIBODY FUSION PROTEIN AND USE THEREOF" on Jul 25, 2025. With publication no. WO/2026/021575, the details related to the patent application was published...

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

INTERNATIONAL PATENT: GMAX BIOPHARM LLC, 鸿运华宁（杭州）生物医药有限公司 FILES APPLICATION FOR "PHARMACEUTICALLY STABLE SOLUTION FORMULATION WITH GIPR ANTIBODY FUSION PROTEIN AND USE THEREOF"